The Last Dance for Chemotherapy Intensification in Non-Asian Advanced Biliary Tract Cancers?

Affiliations

¹ Massimiliano Salati, MD, Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy; PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy; and Alessandro Rizzo, MD, Struttura Semplice Dipartimentale di Oncologia Medica per la presa in carico globale del paziente oncologico "Don Tonino Bello," IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.

Comment

Massimiliano Salati et al. J Clin Oncol. 2022.

. 2022 Apr 20;40(12):1389-1390.

doi: 10.1200/JCO.21.02509. Epub 2022 Mar 2.

¹ Massimiliano Salati, MD, Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy; PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy; and Alessandro Rizzo, MD, Struttura Semplice Dipartimentale di Oncologia Medica per la presa in carico globale del paziente oncologico "Don Tonino Bello," IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.

No abstract available

Comment in

Reply to M. Salati et al.
Phelip JM, Malka D. Phelip JM, et al. J Clin Oncol. 2022 Apr 20;40(12):1390-1391. doi: 10.1200/JCO.22.00057. Epub 2022 Mar 2. J Clin Oncol. 2022. PMID: 35235375 No abstract available.

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.
Phelip JM, Desrame J, Edeline J, Barbier E, Terrebonne E, Michel P, Perrier H, Dahan L, Bourgeois V, Akouz FK, Soularue E, Ly VL, Molin Y, Lecomte T, Ghiringhelli F, Coriat R, Louafi S, Neuzillet C, Manfredi S, Malka D; PRODIGE 38 AMEBICA Investigators/Collaborators. Phelip JM, et al. J Clin Oncol. 2022 Jan 20;40(3):262-271. doi: 10.1200/JCO.21.00679. Epub 2021 Oct 18. J Clin Oncol. 2022. PMID: 34662180 Clinical Trial.